To assess the concordance of SVR12 with SVR4 and treatment completion as indicators of hepatitis C cure in people who inject drugs, highlighting the significance of these measures in clinical practice.
Key Findings:
84% of participants attained SVR12, indicating a high success rate.
PPV of treatment completion for SVR12 was 96.6%, suggesting strong predictive value.
NPV of treatment completion for SVR12 was 100%, indicating no false negatives.
PPV of SVR4 for SVR12 was 100%, confirming its reliability.
NPV of SVR4 for SVR12 was 100%, reinforcing its effectiveness.
Interpretation:
Both SVR4 and treatment completion are reliable indicators of hepatitis C cure, particularly in populations with a history of injection drug use, which may influence future clinical guidelines.
Limitations:
Small sample size of 69 participants, which may limit generalizability.
Potential biases due to convenience sampling, affecting the robustness of the findings.
Conclusion:
SVR4 and treatment completion are effective alternative measures for assessing hepatitis C cure in people who inject drugs, supporting updated clinical guidelines and addressing health disparities.
